Gennemgang af et Cochrane-review vedrørende sekvensen af adjuverende kemoterapi og postoperativ strålebehandling ved brystkræft

Ugeskrift for Laeger

Volumn 169, Issue 37, 2007, Pages 3101-3104

  Nielsen, Hanne Melgaard ^a   Overgaard, Marie ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; BREAST TUMOR; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; MORTALITY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; SEGMENTAL MASTECTOMY;

BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS;

EID: 35148854472     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (10)

1. Arcangeli G, Pinnaro P, Rambone R et al. A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early-stage breast cancer. Int J Radiat Oncol Biol Phys 2006;64:161-7.
2. Calais G. Radiation and concomitant chemotherapy after surgery for breast cancer. Cancer Radiother 2004;8:39-47.
3. Bellon JR, Come SE, Gelman RS et al. Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: updated results of a prospective randomized trial. J Clin Oncol 2005;23:1934-40.
4. Recht A, Come SE, Henderson IC et al. The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer. N Engl J Med 1996;334:1356-61.
5. Shapiro CL, Hardenbergh PH, Gelman R et al. Cardiac effects of adjuvant doxorubicin and radiation therapy in breast cancer patients. J Clin Oncol 1998;16:3493-501.
6. Kurtz J. The curative role of radiotherapy in the treatment of operable breast cancer. Eur J Cancer 2002;38:1961-74.
7. Overgaard M, Hansen PS, Overgaard J et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 1997;337:949-55.
8. Huang J, Barbera L, Brouwers M et al. Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review. J Clin Oncol 2003;21:555-63.
9. Nielsen HM, Overgaard M, Grau C et al. Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and randomized studies. J Clin Oncol 2006;24:2268-75.
10. Halyard MY, Pisansky TM, Pierce LJ et al. Adjuvant radiotherapy and trastuzumab in stage I-II A breast cancer: toxicity data from North Central Cancer Treatment Group- Phase III trial N983. Proc Am Soc Clin Oncol 2006:Abst. 523.